statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	720
IT - Italia	388
SG - Singapore	217
CN - Cina	178
DE - Germania	137
GB - Regno Unito	106
HK - Hong Kong	71
SE - Svezia	70
VN - Vietnam	68
BR - Brasile	67
FI - Finlandia	53
FR - Francia	39
RU - Federazione Russa	36
BD - Bangladesh	34
KR - Corea	26
BE - Belgio	24
NL - Olanda	22
IN - India	21
ID - Indonesia	15
PL - Polonia	15
TR - Turchia	15
MX - Messico	12
CA - Canada	11
BO - Bolivia	9
IE - Irlanda	9
RO - Romania	8
AR - Argentina	7
BG - Bulgaria	7
CL - Cile	7
ES - Italia	6
IQ - Iraq	5
JP - Giappone	5
AT - Austria	4
LT - Lituania	4
PK - Pakistan	4
ZA - Sudafrica	4
CO - Colombia	3
KZ - Kazakistan	3
MA - Marocco	3
CH - Svizzera	2
CI - Costa d'Avorio	2
CY - Cipro	2
EG - Egitto	2
IL - Israele	2
MY - Malesia	2
PY - Paraguay	2
SA - Arabia Saudita	2
TH - Thailandia	2
TN - Tunisia	2
UY - Uruguay	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
AM - Armenia	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
EC - Ecuador	1
ET - Etiopia	1
GT - Guatemala	1
HN - Honduras	1
IR - Iran	1
JO - Giordania	1
KG - Kirghizistan	1
NI - Nicaragua	1
PA - Panama	1
PE - Perù	1
QA - Qatar	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
UA - Ucraina	1
VE - Venezuela	1
Totale	2.475

Nome	#
1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against Acinetobacter baumannii Cephalosporinase	827
Design e Sintesi di Composti Contenenti Boro e loro uso come Antibatterici	357
Straightforward synthesis of chiral non-racemic α-boryl isocyanides	243
Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses	240
α-Triazolylboronic Acids: A Promising Scaffold for Effective Inhibitors of KPCs	201
Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits Acinetobacter-Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum	179
α‐Triazolylboronic Acids: A Novel Scaffold to Target FLT3 in AML	170
Sulfonamidoboronic Acids as “Cross-Class” Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in Acinetobacter baumannii	169
Restoring cefepime activity against multidrug-resistant KPC-producing Klebsiella pneumoniae by combination with boronic acid inhibitors, MB076 and S02030	104
Totale	2.490

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	3	0	0	0	0	0	0	0	0	0	0	0	3
2021/2022	149	4	23	6	25	11	13	7	13	20	7	13	7
2022/2023	222	31	11	12	34	21	32	7	13	30	8	14	9
2023/2024	255	5	22	12	31	42	27	20	22	9	13	15	37
2024/2025	550	23	12	11	23	80	67	43	41	105	11	70	64
2025/2026	1.216	68	87	159	109	128	52	108	67	111	179	60	88
Totale													2.490